Trial Profile
A Phase I Trial of Inhaled Iloprost for the Prevention of Lung Cancer in Former Smokers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Nov 2023
Price :
$35
*
At a glance
- Drugs Iloprost (Primary)
- Indications Lung cancer
- Focus Adverse reactions
- 27 Nov 2023 Status changed from active, no longer recruiting to completed.
- 06 Dec 2019 Planned primary completion date changed from 1 Dec 2019 to 26 Apr 2020.
- 03 Dec 2019 Status changed from recruiting to active, no longer recruiting.